Prelude Capital Management, LLC Accuray Inc Transaction History

Prelude Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$2.44 - $3.08 $10,799 - $13,632	-4,426 Reduced 18.44%	19,574 $55,000
Q3 2023 Nov 14, 2023	BUY	$2.63 - $4.26 $63,120 - $102,240	24,000 New	24,000 $65,000
Q3 2019 Nov 14, 2019	SELL	$2.58 - $4.14 $5,946 - $9,542	-2,305 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$3.54 - $4.64 $8,159 - $10,695	2,305 New	2,305 $9,000
Q4 2017 Feb 14, 2018	SELL	$3.95 - $5.3 $32,409 - $43,486	-8,205 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$3.9 - $4.6 $31,999 - $37,743	8,205	8,205 $33,000

135

56M

26.2K

12.8K

Ticker ARAY
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 93,579,696
Market Cap $183M
Description
Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the Americas, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region. It offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation the...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.